ALZA Corp Articles

Aronex Appointment

12 June 1997

US Quarterly Financial Results Round-Up

5 May 1997

Alkermes Sells $50m Of Stock To Alza

7 April 1997

US Bioscience Completes $21.5 Mill Share Sale To Alza

26 March 1997

Alza Corp Licenses TDC OROS Product; Marketing Deal With Knoll

24 February 1997

Alza To License Testosterone Product From Therapeutic Discovery Corp

10 February 1997

US Launch For Ethyol

29 April 1996

Additional Indication For Alza's Ethyol In USA

25 March 1996

NEW YORK STOCK COMMENT

19 February 1996

Upbeat Alza Unveils Revamped Pipeline

19 February 1996

Alza appointment

18 December 1995

Alza announce stucture of new regulatory advisory board

31 July 1995

End Of Year Encouraging For US Companies

6 February 1995

Alza Gains Efidac Approval

5 December 1994

ALZA APPOINTMENTS

4 July 1994

ACTISITE CLEARED FOR MARKET IN USA

11 April 1994

PETER STAPLE

28 February 1994

ALZA FORECAST

28 June 1993

MURPHY'S LAW PERVADES US DRUG STOCKS

17 May 1993

ADVANCES AND SLOW DOWNS IN US 1st QTRS

3 May 1993

FDA YEAR-END DRUG APPROVALS ROLL-OUT

4 January 1993

PFIZER TO FILE NDA FOR DIABETES DRUG

14 December 1992

GOOD GROWTH FOR US COMPANIESCONTINUES FOR US COs

3 August 1992

NICOTINE PATCH SHORTAGE IN USA

1 June 1992

NEW DELIVERY SYSTEM FROM ALZA

18 May 1992

GOOD 1st QTRs for ALZA, IMMUNEX AND MYLAN

4 May 1992

1991 OUTSTANDING YEAR FOR AMERICAN HOME

6 April 1992

1991 OUTSTANDING YEAR FOR AMERICAN HOME

6 April 1992

ALZA PRODUCT PROMOTIONS

20 January 1992

FEWER ACQUISITIONS AND MERGERS IN 1991

6 January 1992

MMD TO RESTART NICODERM SALES

6 January 1992

Showing 101-131 of 131 articles

Go to beginningPreviousNextGo to end